Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.

NCT01466114 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01466114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2011
Completion date
April 30, 2022
Enrollment
64 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

primary-progressive multiple sclerosis, relapsing-remitting multiple sclerosis, secondary-progressive multiple sclerosis